National Institute on Aging (NIA)

Search Our Work by NIH Institute/Center

Partnerships with this Institute

Completed Programs, Past Programs

Alzheimer's Disease Neuroimaging Initiative (ADNI)

First described more than 100 years ago, Alzheimer’s disease (AD) has no cure or lasting, effective treatment. Currently, more than 5 million people in the United States suffer from it and its incidence is projected to increase dramatically over the next 20 years.

Key Initiatives, Research Partners

The Biomarkers Consortium

This groundbreaking initiative expands the science of targeted medicine. The study of biomarkers creates the potential to individualize medical treatment by determining how a drug works in the body and identifying patients likely to respond to targeted medicines and therapies.

Program, Research Partners

Consensus Definition of Clinically Important Sarcopenia

Sarcopenia is common among older adults, resulting in serious consequences such as disability, increased mortality, and negative effects on co-morbid conditions. It is currently unrecognized as a disease state within the healthcare industry because there is a lack of uniform criteria for its diagnosis and severity.

Completed Programs, Program

Osteoarthritis Initiative (OAI) II

The most common type of arthritis, osteoarthritis affects over 15 million people in the United States. Working in collaboration, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute on Aging (NIA), the and the private sector are striving to improve the efficiency of drug development and clinical trials for the treatment of osteoarthritis.

Program, Research Partners

ADNI II: Alzheimer's Disease Neuroimaging Initiative

As many as 5.3 million Americans are currently living with Alzheimer's disease. Today, there is no cure, no disease-modifying treatment, and no way to prevent the disease. ADNI II aims to build on the success of ADNI, which concluded in 2010. ADNI study investigators have submitted a grant renewal application to the NIH to continue the ADNI study for an additional five years (From late 2010 to late 2015).

Program, Research Partners

Research Partnership in Cognitive Aging

The Research Partnership in Cognitive Aging is a public-private effort between the National Institute on Aging, the McKnight Brain Research Foundation, and the Foundation for NIH to support current and emerging research on age-related changes in the brain influencing cognition and memory loss associated with normal aging.

Completed Programs, Program

Osteoarthritis Initiative (OAI)

Osteoarthritis—the most common form of arthritis—is a degenerative joint disease, and the major cause of physical limitations and disability in older people. Today, 35 million people (13 percent of the U.S. population) are 65 and older, and more than half of them have clear evidence of osteoarthritis in at least one joint. By 2030, 20 percent of Americans (about 70 million people) will have passed their 65th birthday and will be at risk for osteoarthritis.

Donate button

What is the National Institutes of Health?

The National Institutes of Health (NIH) is a part of the U.S. Department of Health and Human Services. Comprised of 27 institutes and centers, the NIH is the primary federal agency for conducting and supporting medical research.

NIH scientists investigate ways of treating, preventing, and even curing common and rare diseases. Learn more by visiting NIH's Web site.

Latest Press Releases
Foundation for the NIH Awards Lurie Prize to Ruslan M. Medzhitov for Groundbreaking Discoveries in the Immune System
FNIH And Geoffrey Beene Foundation Alzheimer’s Initiative Launch Innovation Challenge to Male/Female Differences in Alzheimer’s Disease
The Foundation for the NIH Biomarkers Consortium Begins Development of Patient-Reported Outcome Measures for Community-Acquired Pneumonia and Skin Infections
Foundation for the NIH Joins NIH In Seeking Proposals to Study Sports-Related Brain Injuries
Foundation for the NIH Announces Lurie Prize Recognizing Outstanding Achievement by a Young Biomedical Scientist
More »